Kaleido Biosciences, Inc. Banner Image

Kaleido Biosciences, Inc.

  • Ticker KLDO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kaleido Biosciences, Inc. Logo Image
  • 51-200 Employees
  • Based in Lexington, Massachusetts
Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolicMore output and profile of the microbiome by driving the function and distribution of the gut’s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.
4.8 / 5.0 (144)

Kaleido Biosciences, Inc. reports have an aggregate usefulness score of 4.8 based on 144 reviews.

Kaleido Biosciences, Inc.

Most Recent Annual Report

Kaleido Biosciences, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports

Kaleido Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!